Log in
Enquire now
‌

US Patent 10022424 Use of gelsolin to treat infections

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10022424
Date of Patent
July 17, 2018
Patent Application Number
11129670
Date Filed
May 12, 2005
Patent Citations Received
‌
US Patent 11969461 Composition comprising botulinum toxin
0
‌
US Patent 10603353 Recombinant clostridial neurotoxins with increased duration of effect
‌
US Patent 11357821 Recombinant clostridial neurotoxins with increased duration of effect
‌
US Patent 11952601 Recombinant botulinum toxin with increased duration of effect
0
Patent Primary Examiner
‌
Albert M Navarro
Patent abstract

The invention relates to the use of gelsolin to treat infections and to monitor the treatment of infections. The invention also provides methods up-regulating interleukin expression and methods for down-regulating pro-inflammatory cytokine expression.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10022424 Use of gelsolin to treat infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.